Description
Cefrotic 250 is a Cefuroxime Axetil tablet formulation, a second-generation cephalosporin antibiotic positioned for bacterial infection management. It is a prescription antibiotic, part of Manfaith’s anti-infective product range.
Composition & Strength
Cefuroxime Axetil IP 250 mg (Tablets)
Key Formulation Component and Its Role
- Cefuroxime Axetil – A second-generation cephalosporin antibiotic with broad-spectrum antibacterial activity; works by inhibiting bacterial cell wall synthesis, supporting action against susceptible bacteria across a range of Gram-positive and Gram-negative infections, as prescribed by a physician
Indications / Medical Uses
- Upper and lower respiratory tract infections
- Acute sinusitis, pharyngitis and tonsillitis
- Otitis media (ear infections)
- Urinary tract infections (UTIs)
- Skin and soft tissue infections
Packaging & Key Features
- Available as tablets, 10×10 pack
- Second-generation cephalosporin formulation for broad-spectrum bacterial infection management
- Prescription product (Rx) intended for use under medical supervision
Cefrotic 250 for PCD Pharma Franchise
Cefrotic 250 Tablets is part of Manfaith’s anti-infective product range and is available for PCD pharma franchise and third-party manufacturing partnerships in India. Its Cefuroxime Axetil formulation makes it a relevant addition to a PCD pharma franchise portfolio focused on antibiotic and anti-infective care for pharmaceutical distributors and franchise partners, and complements the Cefrotic 500 strength within the same range.
